Century Therapeutics, Inc. (IPSC) Investor Relations Documents

Century Therapeutics, Inc. (IPSC) investor relations documents from the company's IR site: 2 presentations, 33 press releases; latest deck 2026-08-12. Read in-app with summaries. First-party data.

Century Therapeutics Corporate Overview August 2026: Century Therapeutics secures $135M PIPE in 2026 to advance T1D and autoimmune cell therapies, funding operations to 1Q29.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-12PresentationCentury Therapeutics Corporate Overview August 2026
2026-08-12Press releaseCentury Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
2026-07-09Press releaseCentury Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Cli
2026-06-08Press releaseNew CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalabl
2026-06-07PresentationCNTY-813 preclinical data oral presentation at ADA 2026
2026-05-13Press releaseCentury Therapeutics Reports First Quarter Financial Results and Business Updates
2026-04-30Press releaseCentury Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86
2026-03-12Press releaseCentury Therapeutics Reports Full Year 2025 Financial Results and Business Updates
2026-02-25Press releaseCentury Therapeutics to Participate in Upcoming Investor Conferences in March
2026-01-08Press releaseCentury Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813,
2025-12-09Press releaseCentury Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
2025-11-25Press releaseCentury Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
2025-11-13Press releaseCentury Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
2025-04-28Press releaseCentury Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
2025-04-15Press releaseCentury Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoi
2025-03-19Press releaseCentury Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
2024-11-26Press releaseCentury Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
2024-11-05Press releaseCentury Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
2024-09-26Press releaseCentury Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Offic
2024-08-08Press releaseCentury Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
2024-05-10Press releaseCentury Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 AS
2024-05-09Press releaseCentury Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
2024-03-14Press releaseCentury Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
2023-11-09Press releaseCentury Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
2023-08-09Press releaseCentury Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
2023-05-11Press releaseCentury Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
2023-03-16Press releaseCentury Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates
2022-11-10Press releaseCentury Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
2022-11-02Press releaseCentury Therapeutics to Host Virtual Research and Development Day on November 11, 2022
2022-08-11Press releaseCentury Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates
2022-06-06Press releaseCentury Therapeutics to Host Virtual Research and Development Day on June 13, 2022
2022-05-16Press releaseCentury Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
2022-03-17Press releaseCentury Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates
2021-11-10Press releaseCentury Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
2021-08-12Press releaseCentury Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates

IPSC overview · IPSC earnings · IPSC financials · IPSC KPIs · IPSC ownership · IPSC peers · IPSC filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.